NEXGEL, INC. Files 8-K on Financials
Ticker: NXGLW · Form: 8-K · Filed: Oct 10, 2024 · CIK: 1468929
| Field | Detail |
|---|---|
| Company | Nexgel, Inc. (NXGLW) |
| Form Type | 8-K |
| Filed Date | Oct 10, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k, company-update
Related Tickers: NXGL
TL;DR
NEXGEL filed an 8-K on Oct 10th with financial updates.
AI Summary
On October 10, 2024, NEXGEL, INC. filed an 8-K report detailing results of operations and financial condition. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its fiscal year ends on December 31st.
Why It Matters
This 8-K filing provides crucial updates on NEXGEL, INC.'s financial performance and condition, which is essential for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a standard 8-K reporting financial information and does not indicate any immediate or unusual risks.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
Key Players & Entities
- NEXGEL, INC. (company) — Registrant
- October 10, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 2150 Cabot Boulevard West, Suite B (address) — Business address
- Langhorne, Pennsylvania (location) — City and State of business address
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported is dated October 10, 2024.
What is NEXGEL, INC.'s state of incorporation?
NEXGEL, INC. is incorporated in Delaware.
What is the business address of NEXGEL, INC.?
The business address is 2150 Cabot Boulevard West, Suite B, Langhorne, Pennsylvania.
What is the SIC code for NEXGEL, INC.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 538 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-10-10 09:10:16
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 NXGL The Nasdaq Capital Market LLC
Filing Documents
- form8-k.htm (8-K) — 44KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 12KB
- 0001493152-24-040673.txt ( ) — 292KB
- nxgl-20241010.xsd (EX-101.SCH) — 4KB
- nxgl-20241010_def.xml (EX-101.DEF) — 26KB
- nxgl-20241010_lab.xml (EX-101.LAB) — 36KB
- nxgl-20241010_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition On October 10, 2024, NexGel, Inc. issued a press release reporting preliminary, unaudited summary revenue results for the quarter ended September 30, 2024. The preliminary results presented in the press release remain subject to the completion of customary quarter-end adjustments. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated by reference herein. The information in Item 2.02 of this Current Report on Form 8-K, including the information set forth in Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), nor shall Exhibit 99.1 filed herewith be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued October 10, 2024. 104 Cover Page Interactive Data File (formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 10, 2024 NEXGEL, INC . By: /s/ Adam Levy Adam Levy Chief Executive Officer